Duchesnay Inc. et al v. Hetero Labs Limited et al
| Duchesnay Inc., Shionogi Inc. and QuatRx Pharmaceuticals Company |
| Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero Drugs Limited and Hetero USA Inc. |
| 1:2021cv01130 |
| August 3, 2021 |
| US District Court for the District of Delaware |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 3, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
SO ORDERED, re (16 in 1:21-cv-00538-LPS, 10 in 1:21-cv-01130-LPS) Stipulation and Order Regarding Scheduling Order filed by Hetero Labs Limited Unit-V, Hetero USA Inc., Hetero Labs Limited, Hetero Drugs Limited. Signed by Judge Leonard P. Stark on 9/3/21. Associated Cases: 1:21-cv-00538-LPS, 1:21-cv-01130-LPS (ntl)
|
| Filing 10 STIPULATION regarding Scheduling Order by Hetero Drugs Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc.. (Poff, Adam) |
| Filing 9 WAIVER OF SERVICE returned executed by Shionogi Inc., Duchesnay Inc., QuatRx Pharmaceuticals Company: For Hetero Drugs Limited waiver sent on 8/17/2021, answer due 10/18/2021. (Joyce, Alexandra) |
| Filing 8 WAIVER OF SERVICE returned executed by Shionogi Inc., Duchesnay Inc., QuatRx Pharmaceuticals Company: For Hetero USA Inc. waiver sent on 8/17/2021, answer due 10/18/2021. (Joyce, Alexandra) |
| Filing 7 WAIVER OF SERVICE returned executed by Shionogi Inc., Duchesnay Inc., QuatRx Pharmaceuticals Company: For Hetero Labs Limited waiver sent on 8/17/2021, answer due 10/18/2021. (Joyce, Alexandra) |
| Filing 6 WAIVER OF SERVICE returned executed by Shionogi Inc., Duchesnay Inc., QuatRx Pharmaceuticals Company: For Hetero Labs Limited Unit-V waiver sent on 8/17/2021, answer due 10/18/2021. (Joyce, Alexandra) |
| Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Shionogi Inc. for QuatRx Pharmaceuticals Company; Corporate Parent Shionogi & Co.,Ltd. for Shionogi Inc. filed by Duchesnay Inc., QuatRx Pharmaceuticals Company, Shionogi Inc. (apk) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,245,819 ;8,236,861. (apk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/22/2021. Date of Expiration of Patent: SEE ANDA FORM.Thirty Month Stay Deadline: 12/22/2023. (apk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (apk) |
| Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Hetero Drugs Limited, Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number BDEDC-3671609.) - filed by Shionogi Inc., Duchesnay Inc., QuatRx Pharmaceuticals Company. (Attachments: #1 Exhibit A-C, #2 Civil Cover Sheet)(apk) |
| No Summons Issued. (apk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
